- Exercise Capacity in Patients With Obstructive Hypertrophic Cardiomyopathy: SEQUOIA-HCM Baseline Characteristics and Study Design2024 | Publication without faculty affiliation
- Effects of varying ethanol dosing in percutaneous septal ablation for obstructive hypertrophic cardiomyopathy on early hemodynamic changes2005 | Publication without faculty affiliation
- Follow-Up of Up to 25 Years After Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy2023 | Publication without faculty affiliation
- Effect of Mavacamten on Echocardiographic Features in Symptomatic Patients With Obstructive Hypertrophic Cardiomyopathy2021 | First Faculty of Medicine
- Outcomes of Alcohol Septal Ablation in Younger Patients With Obstructive Hypertrophic Cardiomyopathy2017 | Publication without faculty affiliation
- Cardiac multimarker testing in non-obstructive hypertrophic cardiomyopathy2016 | Faculty of Medicine in Hradec Králové
- Invasive therapies for symptomatic obstructive hypertrophic cardiomyopathy2023 | Publication without faculty affiliation
- Improvement of left ventricular diastolic function after alcohol septal ablation for obstructive hypertrophic cardiomyopathy? Yes, of course, but ...2006 | Publication without faculty affiliation
- Infective endocarditis after alcohol septal ablation for obstructive hypertrophic cardiomyopathy2008 | Second Faculty of Medicine
- N-terminal pro BNP and echocardiographic parameters in patients with non-obstructive hypertrophic cardiomyopathy2015 | Faculty of Medicine in Hradec Králové
- Alcohol septal ablation for obstructive hypertrophic cardiomyopathy: ultra-low dose of alcohol (1 ml) is still effective2009 | Publication without faculty affiliation
- Long-term clinical outcome after alcohol septal ablation for obstructive hypertrophic cardiomyopathy: results from the Euro-ASA registry2016 | Publication without faculty affiliation
- Relation between ethanol dose and clinical outcomes in patients undergoing percutaneous septal ablation for obstructive hypertrophic cardiomyopathy: A prospective, randomized study2005 | Publication without faculty affiliation
- Long-Term Effects of Varying Alcohol Dosing in Percutaneous Septal Ablation for Obstructive Hypertrophic Cardiomyopathy: A Randomized Study With a Follow-up up to 11 Years2011 | Publication without faculty affiliation
- Mid-Term Outcomes of Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy in Patients With Sigmoid Versus Neutral Ventricular Septum2012 | Publication without faculty affiliation
- Impact of ethanol dosing on the long-term outcome of alcohol septal ablation for obstructive hypertrophic cardiomyopathy - A single-center, prospective, and randomized study2006 | Publication without faculty affiliation
- Myectomy-Like Extended Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy2016 | Publication without faculty affiliation
- Outcome of patients >= 60 years of age after alcohol septal ablation for hypertrophic obstructive cardiomyopathy2019 | Publication without faculty affiliation
- Effect of Institutional Experience on Outcomes of Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy2018 | Publication without faculty affiliation